Melanoma Research Foundation (MRF):

CURE OM Options Bring Hope Team Award (CURE OM): Funds an investigative team whose research will advance treatment for all patients with metastatic uveal melanoma (i.e. not restricted by HLA type). Teams should consist of a PI and at least one co-PI, ideally from different institutions. Teams consisting of both basic scientists and clinicians are encouraged, as is the inclusion of a junior scientist. Funding: up to $250K over 2 years.

Breakthrough Consortium Young Investigator Team Award to Advance the Field of Translational Immuno-Oncology (MRFBC): Funds research focuses on either improving clinical outcomes for patients with melanoma being treated with immuno‐oncology agents or advancing the scientific understanding of immuno‐oncology and the role of the immune system in melanoma. PI and all co-PIs must be junior scientists, all of whom have at least one mentor and must involve collaborations from at least two different institutions (one of which must be a MRFBC member institution). Funding: up to $150K/ year for 2 years.

https://melanoma.org/research-science/research-grants/research-grant-rfps/

https://melanoma.org/wp-content/uploads/2023/04/MRFBC-CURE-OM-RFP-Team-Awards-FINAL.pdf